A detailed history of Tcg Advisory Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tcg Advisory Services, LLC holds 11,599 shares of BMY stock, worth $460,016. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,599
Previous 11,258 3.03%
Holding current value
$460,016
Previous $577,000 9.01%
% of portfolio
0.03%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $16,361 - $18,550
341 Added 3.03%
11,599 $629,000
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $271,681 - $324,191
5,604 Added 99.12%
11,258 $577,000
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $44,459 - $49,712
768 Added 15.72%
5,654 $328,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $27,650 - $30,701
-434 Reduced 8.16%
4,886 $312,000
Q1 2023

Apr 24, 2023

BUY
$65.71 - $74.53 $43,171 - $48,966
657 Added 14.09%
5,320 $368,000
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $2,602 - $3,081
-38 Reduced 0.81%
4,663 $335,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $3,989 - $2.36 Million
-30,687 Reduced 86.72%
4,701 $334,000
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $139,648 - $153,801
1,923 Added 5.75%
35,388 $2.73 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $40,146 - $48,139
-653 Reduced 1.91%
33,465 $2.44 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $77,763 - $90,654
1,450 Added 4.44%
34,118 $2.13 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $99,938 - $117,064
1,689 Added 5.45%
32,668 $1.93 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $318,031 - $346,336
5,137 Added 19.88%
30,979 $2.07 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $369,035 - $415,056
6,219 Added 31.69%
25,842 $1.63 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $1.13 Million - $1.28 Million
19,623 New
19,623 $1.18 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tcg Advisory Services, LLC Portfolio

Follow Tcg Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Advisory Services, LLC with notifications on news.